News from National Institute for Medical Research - Mbeya Medical Research Centre

Featured
FAQs for PrEPVacc's vaccine result
FAQs for PrEPVacc's vaccine result
Read more →
Media coverage of PrEPVacc's July 2024 vaccine result announcement
Media coverage of PrEPVacc's July 2024 vaccine result announcement
Read more →
Taarifa kwa Umma: Chanjo za VVU zilizojaribiwa katika utafiti wa PrEPVacc zashindwa kupunguza maambukizi
Taarifa kwa Umma: Chanjo za VVU zilizojaribiwa katika utafiti wa PrEPVacc zashindwa kupunguza maambukizi
Read more →
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
News Release: HIV vaccines tested in PrEPVacc fail to reduce infections
Read more →
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
AIDS 2024: Knowledge and experiences of participating in an HIV vaccine efficacy trial with second randomization to oral pre-exposure prophylaxis in South Africa, Tanzania, and Uganda
Read more →
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next
AVAC briefing on PrEPVacc: An in-depth look at the trial, and what’s next
Read more →
News Release: Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, PrEPVacc study reports
News Release: Experimental HIV vaccine regimens likely to be ineffective in preventing HIV acquisition, PrEPVacc study reports
Read more →
News Release: African-led PrEPVacc HIV prevention study completes its enrolment
News Release: African-led PrEPVacc HIV prevention study completes its enrolment
Read more →
Video to help inform PrEPVacc participants posted online
Video to help inform PrEPVacc participants posted online
Read more →
PrEPVacc featured in JIAS articles in Nov 2021
PrEPVacc featured in JIAS articles in Nov 2021
Read more →